drugset / Trial / NCT03341832

Efficacy and Safety of NVP-1203 in Patients With Acute Low Back Pain

NCT03341832

Phase 2 Completed 91 enrolled NVP Healthcare
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety NVP-1203 in patients with Acute low back pain

Timeline

Start
2018-01-31
Primary completion
2019-01-15
Completion
2019-01-15

Drugs

EvaluationDrugModalityDoseRoute
Subject NVP-1203 Unknown Oral
Comparator NVP-1203-R Unknown Oral

Indications

No indication recorded.